Intravitreally injected platelet activating factor induces retinitis in experimental animals

James (Jim) Rosenbaum, Ethan Angell, David Wilson, Colette Broquet, Richard S. Boney, Pierre Braquet

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose. Platelet activating factor is a lipid which has been strongly implicated in anterior uveitis. In order to investigate further the role of platelet activating factor in intraocular inflammation, we have characterized the histological changes associated with the intravitreal injection of platelet activating factor, PAF analogs, or lyso-PAF in laboratory rabbits and rats. Methods. Initial studies utilized a PAF analog (rac 1-O-octadecyl 2-O-ethyl glycero phosphoryl choline or ethoxy PAF), because this compound is relatively resistant to degradation by hydrolase, the major degradative enzyme for PAF. Doses ranging from 1 ug to 5 mg and time points from 6 hours to 7 days after injection were studied. Results. In either rats or rabbits, 100 ug of ethoxy PAF consistently induced a marked uveitis with the predominance of inflammation focused in the retina and choroid. Retinitis was also induced in rabbits by either 1 mg PAF injected intravitreally or a similar dose of the PAF precursor/metabolite, lyse PAF. Retinal inflammation was not induced by an inactive lipid, 1,1-O,O-dihexadecyl-rac-glycero-3-phosphocholine, although this compound resulted in mild vitreous inflammation. The histologicalal changes induced by PAF could be readily distinguished from the predominantly anterior inflammation induced by intravitreal injections of substances such an interleukin-1 or endotoxin. Conclusions. Recent studies indicating that PAF antagonists inhibit a variety of retinal toxicities and our own observations suggest that PAF could be a major mediator of retinal inflammation.

Original languageEnglish (US)
Pages (from-to)342-348
Number of pages7
JournalCurrent Eye Research
Volume18
Issue number5
DOIs
StatePublished - 1999

Fingerprint

Retinitis
Platelet Activating Factor
Inflammation
Intravitreal Injections
Rabbits
Anterior Uveitis
Lipids
Inflammation Mediators
Phosphorylcholine
Choroid
Uveitis
Hydrolases
Choline
Interleukin-1
Endotoxins
Retina
Injections
Enzymes

Keywords

  • Platelet activating factor (PAF)
  • Rabbit
  • Rat
  • Retinitis
  • Uveitis

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Intravitreally injected platelet activating factor induces retinitis in experimental animals. / Rosenbaum, James (Jim); Angell, Ethan; Wilson, David; Broquet, Colette; Boney, Richard S.; Braquet, Pierre.

In: Current Eye Research, Vol. 18, No. 5, 1999, p. 342-348.

Research output: Contribution to journalArticle

Rosenbaum, James (Jim) ; Angell, Ethan ; Wilson, David ; Broquet, Colette ; Boney, Richard S. ; Braquet, Pierre. / Intravitreally injected platelet activating factor induces retinitis in experimental animals. In: Current Eye Research. 1999 ; Vol. 18, No. 5. pp. 342-348.
@article{d4a8b48137de4b0c9606d224e6c247c3,
title = "Intravitreally injected platelet activating factor induces retinitis in experimental animals",
abstract = "Purpose. Platelet activating factor is a lipid which has been strongly implicated in anterior uveitis. In order to investigate further the role of platelet activating factor in intraocular inflammation, we have characterized the histological changes associated with the intravitreal injection of platelet activating factor, PAF analogs, or lyso-PAF in laboratory rabbits and rats. Methods. Initial studies utilized a PAF analog (rac 1-O-octadecyl 2-O-ethyl glycero phosphoryl choline or ethoxy PAF), because this compound is relatively resistant to degradation by hydrolase, the major degradative enzyme for PAF. Doses ranging from 1 ug to 5 mg and time points from 6 hours to 7 days after injection were studied. Results. In either rats or rabbits, 100 ug of ethoxy PAF consistently induced a marked uveitis with the predominance of inflammation focused in the retina and choroid. Retinitis was also induced in rabbits by either 1 mg PAF injected intravitreally or a similar dose of the PAF precursor/metabolite, lyse PAF. Retinal inflammation was not induced by an inactive lipid, 1,1-O,O-dihexadecyl-rac-glycero-3-phosphocholine, although this compound resulted in mild vitreous inflammation. The histologicalal changes induced by PAF could be readily distinguished from the predominantly anterior inflammation induced by intravitreal injections of substances such an interleukin-1 or endotoxin. Conclusions. Recent studies indicating that PAF antagonists inhibit a variety of retinal toxicities and our own observations suggest that PAF could be a major mediator of retinal inflammation.",
keywords = "Platelet activating factor (PAF), Rabbit, Rat, Retinitis, Uveitis",
author = "Rosenbaum, {James (Jim)} and Ethan Angell and David Wilson and Colette Broquet and Boney, {Richard S.} and Pierre Braquet",
year = "1999",
doi = "10.1076/ceyr.18.5.342.5346",
language = "English (US)",
volume = "18",
pages = "342--348",
journal = "Current Eye Research",
issn = "0271-3683",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Intravitreally injected platelet activating factor induces retinitis in experimental animals

AU - Rosenbaum, James (Jim)

AU - Angell, Ethan

AU - Wilson, David

AU - Broquet, Colette

AU - Boney, Richard S.

AU - Braquet, Pierre

PY - 1999

Y1 - 1999

N2 - Purpose. Platelet activating factor is a lipid which has been strongly implicated in anterior uveitis. In order to investigate further the role of platelet activating factor in intraocular inflammation, we have characterized the histological changes associated with the intravitreal injection of platelet activating factor, PAF analogs, or lyso-PAF in laboratory rabbits and rats. Methods. Initial studies utilized a PAF analog (rac 1-O-octadecyl 2-O-ethyl glycero phosphoryl choline or ethoxy PAF), because this compound is relatively resistant to degradation by hydrolase, the major degradative enzyme for PAF. Doses ranging from 1 ug to 5 mg and time points from 6 hours to 7 days after injection were studied. Results. In either rats or rabbits, 100 ug of ethoxy PAF consistently induced a marked uveitis with the predominance of inflammation focused in the retina and choroid. Retinitis was also induced in rabbits by either 1 mg PAF injected intravitreally or a similar dose of the PAF precursor/metabolite, lyse PAF. Retinal inflammation was not induced by an inactive lipid, 1,1-O,O-dihexadecyl-rac-glycero-3-phosphocholine, although this compound resulted in mild vitreous inflammation. The histologicalal changes induced by PAF could be readily distinguished from the predominantly anterior inflammation induced by intravitreal injections of substances such an interleukin-1 or endotoxin. Conclusions. Recent studies indicating that PAF antagonists inhibit a variety of retinal toxicities and our own observations suggest that PAF could be a major mediator of retinal inflammation.

AB - Purpose. Platelet activating factor is a lipid which has been strongly implicated in anterior uveitis. In order to investigate further the role of platelet activating factor in intraocular inflammation, we have characterized the histological changes associated with the intravitreal injection of platelet activating factor, PAF analogs, or lyso-PAF in laboratory rabbits and rats. Methods. Initial studies utilized a PAF analog (rac 1-O-octadecyl 2-O-ethyl glycero phosphoryl choline or ethoxy PAF), because this compound is relatively resistant to degradation by hydrolase, the major degradative enzyme for PAF. Doses ranging from 1 ug to 5 mg and time points from 6 hours to 7 days after injection were studied. Results. In either rats or rabbits, 100 ug of ethoxy PAF consistently induced a marked uveitis with the predominance of inflammation focused in the retina and choroid. Retinitis was also induced in rabbits by either 1 mg PAF injected intravitreally or a similar dose of the PAF precursor/metabolite, lyse PAF. Retinal inflammation was not induced by an inactive lipid, 1,1-O,O-dihexadecyl-rac-glycero-3-phosphocholine, although this compound resulted in mild vitreous inflammation. The histologicalal changes induced by PAF could be readily distinguished from the predominantly anterior inflammation induced by intravitreal injections of substances such an interleukin-1 or endotoxin. Conclusions. Recent studies indicating that PAF antagonists inhibit a variety of retinal toxicities and our own observations suggest that PAF could be a major mediator of retinal inflammation.

KW - Platelet activating factor (PAF)

KW - Rabbit

KW - Rat

KW - Retinitis

KW - Uveitis

UR - http://www.scopus.com/inward/record.url?scp=0032941333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032941333&partnerID=8YFLogxK

U2 - 10.1076/ceyr.18.5.342.5346

DO - 10.1076/ceyr.18.5.342.5346

M3 - Article

VL - 18

SP - 342

EP - 348

JO - Current Eye Research

JF - Current Eye Research

SN - 0271-3683

IS - 5

ER -